Danco Revises Mifeprex Labeling To Add Post-Marketing Adverse Reactions
This article was originally published in The Pink Sheet Daily
Executive Summary
Adverse events for the abortifacient include allergic reactions, hypotension, light-headedness, shortness of breath and tachycardia. Reports of serious infections and ruptured ectopic pregnancies prompted FDA to strengthen Mifeprex’ “black box” warning in November.